French people and gambling
23.09.2020 - Results from the 2019 Santé publique France Barometer in Tendances No. 138.Read more
Drugs in overseas France
26.06.2020 - Overview of the situations and problems currently observed in the French Overseas Territories.Read more
Cannabis sales revenue in France
26.06.2020 - A new direct estimate by expenditure in Tendances No. 137.Read more
Latest news from the EMCDDA
European Drug Report 2020
22.09.2020 - How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2020 European Drug Report, the EMCDDA annual overview of the drug situation in Europe.
Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
06.2020 - The EMCDDA instigated a mixed-method trendspotter study to investigate the current situation.
EU Drug Markets — Impact of COVID-19
05.2020 - Joint publication from the EMCDDA and Europol.
Quick access to the EMCDDA main publications archives
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.